IQT Explains: Biotech and Investments, Part 2

Welcome to another episode of IQT Explains! In Part 2 of our Biotech and Investments series, we continue to explore IQT's cutting-edge work in biotechnology, focusing on our more recent investment activity and breaking down the latest developments in this ever-evolving domain. Our guests, Eugene Chiu and Dr. Michelle Rozo, delve into IQT's unique architectural approach, advancements in mRNA vaccines, gene editing, and AI-enabled biotech, as well as the challenges and opportunities ahead. Tune in for an insightful discussion on the current biotech landscape and its impact on national security.   Key Topics - Global Competition and U.S. Response - Latest Developments and Innovations - Challenges and Opportunities Ahead - Geopolitical Influence - Future Prospects and Potential Risks   Featured in this Episode Farid Nemri Program Manager LinkedIn: https://www.linkedin.com/in/faridnemri/   Eugene Chiu Senior Partner, Investments LinkedIn - https://www.linkedin.com/in/eugenechiu   Dr. Michelle Rozo VP Technology LinkedIn - https://www.linkedin.com/in/michelle-rozo